[go: up one dir, main page]

HUE045723T2 - Módszerek vesebetegség kimutatására - Google Patents

Módszerek vesebetegség kimutatására

Info

Publication number
HUE045723T2
HUE045723T2 HUE14842603A HUE14842603A HUE045723T2 HU E045723 T2 HUE045723 T2 HU E045723T2 HU E14842603 A HUE14842603 A HU E14842603A HU E14842603 A HUE14842603 A HU E14842603A HU E045723 T2 HUE045723 T2 HU E045723T2
Authority
HU
Hungary
Prior art keywords
methods
kidney disease
detecting kidney
detecting
disease
Prior art date
Application number
HUE14842603A
Other languages
English (en)
Inventor
Mahalakshmi Yerramilli
Murthy Yerramilli
Original Assignee
Idexx Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52628954&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE045723(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Idexx Lab Inc filed Critical Idexx Lab Inc
Publication of HUE045723T2 publication Critical patent/HUE045723T2/hu

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806Determination of free amino acids
    • G01N33/6812Assays for specific amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/34Genitourinary disorders
    • G01N2800/347Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/56Staging of a disease; Further complications associated with the disease
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HUE14842603A 2013-09-05 2014-09-05 Módszerek vesebetegség kimutatására HUE045723T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361874011P 2013-09-05 2013-09-05

Publications (1)

Publication Number Publication Date
HUE045723T2 true HUE045723T2 (hu) 2020-01-28

Family

ID=52628954

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14842603A HUE045723T2 (hu) 2013-09-05 2014-09-05 Módszerek vesebetegség kimutatására

Country Status (21)

Country Link
US (3) US11035861B2 (hu)
EP (3) EP3041576B1 (hu)
JP (4) JP6657096B2 (hu)
KR (2) KR102273028B1 (hu)
CN (1) CN105705202B (hu)
AU (2) AU2014315063B2 (hu)
CA (2) CA2923140C (hu)
CY (1) CY1123179T1 (hu)
DK (1) DK3041576T3 (hu)
ES (2) ES2969979T3 (hu)
HR (1) HRP20191569T1 (hu)
HU (1) HUE045723T2 (hu)
LT (1) LT3041576T (hu)
MX (2) MX383274B (hu)
NZ (1) NZ717554A (hu)
PL (1) PL3041576T3 (hu)
PT (1) PT3041576T (hu)
RS (1) RS59287B1 (hu)
SI (1) SI3041576T1 (hu)
SM (1) SMT201900526T1 (hu)
WO (1) WO2015035155A1 (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20191569T1 (hr) 2013-09-05 2019-11-29 Idexx Lab Inc Metode za utvrđivanje bolesti bubrega
FI3259593T3 (fi) 2015-02-20 2023-01-13 Homogeeninen immunomääritys, jossa on taustasignaalikompensointi
AU2016254226C1 (en) 2015-04-30 2022-11-24 Idexx Laboratories, Inc. Methods for detecting renal disease
PT3631472T (pt) 2017-05-31 2022-09-22 Mars Inc Métodos de diagnóstico e tratamento da doença renal crónica
CN111033637B (zh) 2017-08-08 2023-12-05 费森尤斯医疗保健控股公司 用于治疗和评估慢性肾脏疾病的进程的系统和方法
TWI831753B (zh) * 2017-10-19 2024-02-11 美商英代斯實驗公司 對稱性二甲基精胺酸之檢測
WO2020080484A1 (ja) * 2018-10-17 2020-04-23 株式会社 資生堂 糸球体濾過能力の決定方法
CN109545377B (zh) * 2018-10-22 2021-11-23 中南大学湘雅三医院 获取肾小球滤过率的模型的建立方法
US10745492B1 (en) 2019-04-03 2020-08-18 Ark Diagnostics, Inc. Antibodies to symmetrically dimethylated arginine analytes and use thereof
AU2020343654A1 (en) 2019-09-05 2022-03-31 The Regents Of The University Of California Noninvasive method to quantify kidney function and functional decline
JP6993654B2 (ja) * 2019-12-27 2022-02-15 Kagami株式会社 腎機能を推定する方法及びシステム
GB202005110D0 (en) * 2020-04-07 2020-05-20 Royal Veterinary College Diagnosis of stage b2 dmvd
JP7784798B2 (ja) * 2020-04-17 2025-12-12 株式会社藤商事 遊技機
EP4263383A4 (en) 2020-12-17 2024-10-23 Nephrosant, Inc. KITS FOR STABILIZATION OF URINE SAMPLES
CN112768073B (zh) * 2021-01-15 2023-04-18 中山大学附属第三医院 一种肾小球滤过率估计模型的构建方法
JP2023160475A (ja) * 2022-04-22 2023-11-02 株式会社三共 遊技機
KR102880012B1 (ko) * 2023-12-22 2025-11-10 주식회사 페토바이오 반려동물의 신부전 치료를 위한 임상 의사결정 지원 시스템 및 임상 의사결정 지원 방법
CN119125582A (zh) * 2024-09-20 2024-12-13 武汉虹之彩包装印刷有限公司 一种用于肌酐检测的纸基传感器及其制备方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134787A1 (de) * 1981-09-02 1983-03-10 Boehringer Mannheim Gmbh, 6800 Mannheim Creatinin-antikoerper
US4818703A (en) 1985-10-23 1989-04-04 Pizzolante John M Stabilized alkaline picrate reagent for jaffe creatinine determination
EP0356160A3 (en) 1988-08-24 1991-09-11 The Board Of Trustees Of The Leland Stanford Junior University Capillary device
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US6455288B1 (en) 1993-04-08 2002-09-24 Dade Behring Marburg Gmbh Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases
US5804452A (en) * 1995-04-27 1998-09-08 Quidel Corporation One step urine creatinine assays
WO1998049199A1 (en) 1997-05-01 1998-11-05 Panorama Research, Inc. Cardiovascular disease risk assessment
US6736957B1 (en) 1997-10-16 2004-05-18 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors and process for using
US6358699B1 (en) 1999-02-05 2002-03-19 Cooke Pharma Assay for asymmetrical NG, NG dimethyl-l-arginine
US6699673B2 (en) 1999-12-22 2004-03-02 The Research Foundation Of State University Of New York Protein methylarginine-specific antibodies
EP1299398A1 (en) 2000-07-06 2003-04-09 Fal Diagnostics Methods and kits for the detection of arginine compounds
DE60133558D1 (de) * 2000-07-12 2008-05-21 Werner Naser Direkte bestimmung des quotients von analyt- zu referenzmolekülen
DE10040904A1 (de) 2000-08-18 2002-02-28 Boeger Rainer H Verfahren und Mittel zum Nachweis einer Wahrscheinlichkeit zukünftigen Fortschreitens von Gefässerkrankungen
US7241856B2 (en) 2003-06-02 2007-07-10 Pentron Clinical Technologies Llc Dental resins, dental composite materials, and method of manufacture thereof
JP4214271B2 (ja) 2002-10-15 2009-01-28 アークレイ株式会社 クレアチニン測定用試験片
US7501053B2 (en) 2002-10-23 2009-03-10 Abbott Laboratories Biosensor having improved hematocrit and oxygen biases
WO2004046314A2 (en) 2002-11-15 2004-06-03 The Board Of Trustees Of The Leland Stanford Junior University Methods for detecting asymmetric dimethylarginine in a biological sample
US20050148029A1 (en) * 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
ES2332218T3 (es) 2004-11-04 2010-01-29 Germediq Forschungs- Und Entwicklungsgesellschaft Mbh Metodo para la determinacion de arginina, argininas metiladas y sus derivados.
US8687008B2 (en) 2004-11-15 2014-04-01 Nvidia Corporation Latency tolerant system for executing video processing operations
WO2006078813A2 (en) 2005-01-21 2006-07-27 Biosite Incorporated Arginine analogs, and methods for their synthesis and use
JP2007176872A (ja) 2005-12-28 2007-07-12 Sentan Seimei Kagaku Kenkyusho:Kk アシンメトリックジメチルアルギニンを認識する抗体及びその製造方法並びに翻訳後修飾アミノ酸含有タンパク質の検出方法
FR2919063B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
ES2547307T3 (es) 2007-12-05 2015-10-05 King's College London Procedimiento de ayuda al diagnóstico de un trastorno
SI2313364T1 (sl) * 2008-08-07 2021-01-29 Idexx Laboratories, Inc. Metode za detekcijo simetričnega dimetilarginina
CA2763948C (en) 2009-06-02 2019-03-12 Biocrates Life Sciences Ag Combination of amino acids, acylcarnitines and biogenic amines for the assessment of chronic kidney disease
CN101587118B (zh) * 2009-07-03 2012-09-12 长春迪瑞医疗科技股份有限公司 肌酐尿液分析试纸及制备方法
CN101598727B (zh) * 2009-07-09 2012-10-10 上海科华生物工程股份有限公司 定量测定人体血液尿素含量的干化学试纸
US9285246B2 (en) * 2010-02-12 2016-03-15 Intuitive Surgical Operations, Inc. Method and system for absolute three-dimensional measurements using a twist-insensitive shape sensor
CN101865911A (zh) * 2010-03-16 2010-10-20 苏州市玮琪生物科技有限公司 一种尿肌酐定量检测卡
EP2612147B1 (de) 2010-11-17 2016-03-30 Karl-Heinz Kellner Automatenfähiger immunoassay für biogene amine
JP2012112785A (ja) 2010-11-24 2012-06-14 Tohoku Univ 透析膜の評価方法
JP5925026B2 (ja) * 2011-04-28 2016-05-25 アークレイ株式会社 クレアチニン測定用乾式試験片及びクレアチニン測定法
EP2721416A4 (en) * 2011-06-16 2015-01-21 Baylor Res Inst Analysis of total homocysteine and methylmalonic acid in plasma by lc-ms/ms from a plasma separator device (psd)
WO2013115283A1 (ja) * 2012-01-31 2013-08-08 味の素株式会社 早期腎症の評価方法、早期腎症評価装置、早期腎症評価方法、早期腎症評価プログラム、早期腎症評価システムおよび情報通信端末装置
US20140038203A1 (en) * 2012-07-09 2014-02-06 Musc Foundation For Research Development Methods for detecting or predicting kidney disease
HRP20191569T1 (hr) 2013-09-05 2019-11-29 Idexx Lab Inc Metode za utvrđivanje bolesti bubrega

Also Published As

Publication number Publication date
MX383274B (es) 2025-03-13
JP2020073927A (ja) 2020-05-14
US20160187348A1 (en) 2016-06-30
BR112016004839A8 (pt) 2020-02-11
EP4295907A2 (en) 2023-12-27
EP3480600C0 (en) 2023-11-08
ES2746008T3 (es) 2020-03-04
PL3041576T3 (pl) 2019-12-31
US11035861B2 (en) 2021-06-15
EP4295907A3 (en) 2024-03-13
CA2923140A1 (en) 2015-03-12
EP3041576B1 (en) 2019-06-19
AU2020256440B2 (en) 2023-03-02
US20220137059A1 (en) 2022-05-05
KR20210082567A (ko) 2021-07-05
US20250271442A1 (en) 2025-08-28
PT3041576T (pt) 2019-09-27
CA3213810A1 (en) 2015-03-12
HRP20191569T1 (hr) 2019-11-29
SI3041576T1 (sl) 2019-11-29
EP3480600B1 (en) 2023-11-08
CN105705202B (zh) 2019-02-26
JP2016530532A (ja) 2016-09-29
JP2022070879A (ja) 2022-05-13
DK3041576T3 (da) 2019-09-09
AU2014315063B2 (en) 2020-07-23
CN105705202A (zh) 2016-06-22
MX2016002922A (es) 2016-11-07
AU2020256440A1 (en) 2020-11-12
ES2969979T3 (es) 2024-05-23
RS59287B1 (sr) 2019-10-31
KR20160051887A (ko) 2016-05-11
LT3041576T (lt) 2019-10-25
SMT201900526T1 (it) 2019-11-13
CY1123179T1 (el) 2021-10-29
MX2021006716A (es) 2021-07-15
WO2015035155A1 (en) 2015-03-12
CA2923140C (en) 2023-09-26
EP3480600A1 (en) 2019-05-08
EP3041576A1 (en) 2016-07-13
AU2014315063A1 (en) 2016-03-17
EP3041576A4 (en) 2017-07-26
KR102273028B1 (ko) 2021-07-02
NZ717554A (en) 2022-04-29
KR102412431B1 (ko) 2022-06-22
JP2024020376A (ja) 2024-02-14
JP6657096B2 (ja) 2020-03-04

Similar Documents

Publication Publication Date Title
IL285521A (en) Assays for single molecule detection
IL281485B (en) Tracked all-terrain vehicle
HUE045723T2 (hu) Módszerek vesebetegség kimutatására
DK2972351T3 (da) Forbedrede analysemetoder
IL246002A0 (en) Novel methods
DK2881868T3 (da) Søgegrænseflade
BR112016012160A2 (pt) métodos para detecção de infecção de plasmodium
DK3736291T5 (da) Anti-FCRH5-antistoffer
LT3074534T (lt) Būdai, skirti polinukleotido sekoskaitai
LT3060041T (lt) Prostaciklino junginiai
DK3004155T3 (da) Peptidforbindelse
EP2951642A4 (en) OMNISTEREO IMAGING
DK3708583T3 (da) Ikke-fucosylerede anti-fgfr2iiib-antistoffer
PL3495005T3 (pl) Placówka do przeprowadzania zabiegów dializy otrzewnowej
DK2970336T3 (da) Tetrahydropyrrolothiazinforbindelser
DK3613286T3 (da) Fælde
DK3068800T3 (da) FcRn-specifikke antistoffer
IL240753B (en) Methods for purifying antibodies
DK3047188T3 (da) Rørforbindelse
EP2982408A4 (en) INTERCONNECTS
EP2997878A4 (en) ENDOSCOPIC SYSTEM
BR112015021083A2 (pt) método
IL240904A0 (en) Azetidinyloxyphenylpyrrolidine compounds
DK3065774T3 (da) Anti-CCL17-antistoffer
BR112015029076A2 (pt) método